Air India pilot's reported cannabis test: What it can and can't tell investigators

A routine drug screening of an Air India captain returned a positive result for cannabis on 12 May 2024, prompting a formal inquiry by the airline and Indian aviation authorities. The pilot, whose identity has been kept confidential, was scheduled to operate a domestic flight from Delhi to Mumbai when the result surfaced. While the finding raises immediate safety concerns, experts warn that a single positive test does not automatically prove impairment at the time of duty. The case matters because it could shape future policies on substance‑use testing across the global aviation sector.

Key takeaways

  • A cannabis‑positive result triggers an internal investigation, not an automatic suspension.
  • Tests detect metabolites, which may linger long after any intoxicating effect has worn off.
  • Indian regulators must balance safety with privacy and labor‑law protections.
  • The outcome could influence how airlines worldwide handle similar drug‑test alerts.

Background

India’s civil aviation regulator, the Directorate General of Civil Aviation (DGCA), mandates random drug testing for all crew members under the Aviation Safety Act. The policy was tightened in 2022 after a series of high‑profile incidents involving substance use in other countries. Air India, the nation’s flag carrier, follows the same protocol and reports any positive findings to the DGCA for further review. The airline’s safety‑culture framework is outlined on its world page, emphasizing zero tolerance for impairment while respecting employee rights.

What happened

On 12 May, a routine urine sample collected from the pilot showed the presence of THC‑COOH, a metabolite that indicates cannabis consumption. The lab, accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL), flagged the result as “positive” according to the threshold set by the DGCA. Air India immediately grounded the crew member and notified the DGCA, which launched a parallel investigation. The airline also informed its Chronicle News portal, where staff can follow procedural updates.

Why it matters

A positive cannabis test can mean several things: recent use, occasional consumption, or even exposure to second‑hand smoke. Because THC metabolites can stay detectable for up to 30 days in regular users, the result alone does not confirm that the pilot was under the influence while flying. Investigators will therefore examine flight logs, cockpit voice recordings, and any recent medical or personal disclosures. The case arrives at a time when airlines worldwide are re‑evaluating drug‑testing thresholds, as seen in recent debates after the Europe's scorched landscapes seen from space after summer heatwaves article highlighted broader environmental stressors on crew health, and after the Five dead after 7.7 magnitude earthquake strikes Indonesia tragedy underscored the need for robust safety protocols.

What happens next

The DGCA will conduct a forensic review, which may include a confirmatory blood test and an interview with the pilot. If the investigation finds that the pilot was not impaired during duty, the airline may reinstate him after a period of counseling and a clean‑test requirement. Conversely, if evidence suggests a breach of safety standards, disciplinary action could range from suspension to revocation of the pilot’s licence. Air India has pledged transparency and will publish a summary of its findings on its corporate site, while also reviewing its testing frequency and threshold limits.

Frequently asked questions

How reliable are cannabis drug tests for pilots?

Standard urine tests detect THC metabolites, which indicate past use but not current impairment. Aviation regulators therefore combine test results with behavioural assessments and flight data to draw conclusions.

Could second‑hand cannabis smoke cause a false positive?

Second‑hand exposure can produce trace metabolite levels, but they are usually below the DGCA’s cut‑off. Laboratories must follow strict chain‑of‑custody procedures to minimise contamination.

Will this incident change airline drug‑testing policies?

The case may prompt airlines to revisit testing intervals, threshold levels, and education programmes. However, any policy shift will require coordination with the DGCA and alignment with international standards set by the International Civil Aviation Organization (ICAO).

Bottom line

The positive cannabis test has opened a detailed investigation that will determine whether the pilot’s flight duties were compromised. The outcome will likely influence drug‑testing protocols across Indian aviation and possibly beyond, as reported by BBC News.

Related reading